Glaxo's Anoro For Treatment Of COPD Recommended For Marketing Authorisation
LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday that its treatment for chronic obstructive pulmonary disease Anoro had been recommended for marketing authorisation from the European Medicines Agency's committee for Medical Products for Human Use. Glaxo expects a final decision on Read More